Principle Investigator
National Center for Advancing Translational Sciences (NCATS), NIH, Maryland, United States
Dr. James Inglese, Ph.D. directs the Laboratory of Assay Development and Screening Technology (ADST) within the National Center for Advancing Translational Sciences (NCATS, NIH) and is an Adjunct Investigator within the National Human Genome Research Institute (NHGRI, NIH). His laboratory explores strategies aimed at enabling the identification of novel molecular modalities as chemical probes and therapeutic leads for the study and treatment of rare and neglected disease. Prior to the formation of NCATS he co-founded the NIH Chemical Genomics Center (NCGC) acting as its Deputy Director. Dr. Inglese received his Ph.D. in Organic Chemistry from the Pennsylvania State University and completed post-doctoral training in the laboratory Prof. Robert J. Lefkowitz at Duke University Medical Center. Prior to NIH, Dr. Inglese led research teams at the combinatorial chemistry Princeton-based biotech Pharmacopeia and Merck Research Laboratories.
Disclosure information not submitted.
Tuesday, February 8, 2022
4:00 PM – 4:30 PM